Clinical Trial Update: Characterize Flu-like Symptoms in Relapsing Multiple Sclerosis Patients Transitioning From Non-Pegylated Interferon Beta (IFN-β) Therapies to Peginterferon Beta-1a (BIIB017) [Phase 3]

View source ↗

Summary

Phase 3 trial update examining flu-like symptoms in relapsing multiple sclerosis patients switching from non-pegylated interferon beta therapies to peginterfero…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Relapsing Multiple Sclerosis

Drugs mentioned

• Interferon-beta (interferon beta)
• Peginterferon beta-1a (peginterferon beta-1a)

Snippet

Sponsor: Biogen | Conditions: Relapsing Multiple Sclerosis | Phase 3 | Status: COMPLETED | Results posted: 2017-01-25